AstraZeneca Forms a Bigger Chinese Fund Vehicle
Posted on 11/06/2019
AstraZeneca plc is an English-Swedish multinational pharmaceutical and biopharmaceutical company. AstraZeneca formed a new investment fund with China International Capital Corporation (CICC) to invest US$ 1 billion in China’s healthcare sector. AstraZeneca is taking a minority equity position in the fund. Operating in China since 1993, the pharmaceutical giant will mostly play an advisory role […]
